7337 related articles for article (PubMed ID: 25379020)
1. A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.
Biau J; Devun F; Jdey W; Kotula E; Quanz M; Chautard E; Sayarath M; Sun JS; Verrelle P; Dutreix M
Neoplasia; 2014 Oct; 16(10):835-44. PubMed ID: 25379020
[TBL] [Abstract][Full Text] [Related]
2. [Dbait: An innovative concept to inhibit DNA repair and treat cancer].
Biau J; Devun F; Verrelle P; Dutreix M
Bull Cancer; 2016 Mar; 103(3):227-35. PubMed ID: 26917468
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule drugs mimicking DNA damage: a new strategy for sensitizing tumors to radiotherapy.
Quanz M; Berthault N; Roulin C; Roy M; Herbette A; Agrario C; Alberti C; Josserand V; Coll JL; Sastre-Garau X; Cosset JM; Larue L; Sun JS; Dutreix M
Clin Cancer Res; 2009 Feb; 15(4):1308-16. PubMed ID: 19190126
[TBL] [Abstract][Full Text] [Related]
4. The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis.
Herath NI; Devun F; Lienafa MC; Herbette A; Denys A; Sun JS; Dutreix M
Mol Cancer Ther; 2016 Jan; 15(1):15-22. PubMed ID: 26637369
[TBL] [Abstract][Full Text] [Related]
5. Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models.
Biau J; Chautard E; Berthault N; de Koning L; Court F; Pereira B; Verrelle P; Dutreix M
Front Oncol; 2019; 9():549. PubMed ID: 31275862
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation.
Devun F; Biau J; Huerre M; Croset A; Sun JS; Denys A; Dutreix M
Radiology; 2014 Mar; 270(3):736-46. PubMed ID: 24475822
[TBL] [Abstract][Full Text] [Related]
7. First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.
Le Tourneau C; Dreno B; Kirova Y; Grob JJ; Jouary T; Dutriaux C; Thomas L; Lebbé C; Mortier L; Saiag P; Avril MF; Maubec E; Joly P; Bey P; Cosset JM; Sun JS; Asselain B; Devun F; Marty ME; Dutreix M
Br J Cancer; 2016 May; 114(11):1199-205. PubMed ID: 27140316
[TBL] [Abstract][Full Text] [Related]
8. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment.
van Oorschot B; Granata G; Di Franco S; Ten Cate R; Rodermond HM; Todaro M; Medema JP; Franken NA
Oncotarget; 2016 Oct; 7(40):65504-65513. PubMed ID: 27602767
[TBL] [Abstract][Full Text] [Related]
10. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
[TBL] [Abstract][Full Text] [Related]
11. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
Harada T; Harada K; Ueyama Y
Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
[TBL] [Abstract][Full Text] [Related]
13. YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
Stachelek GC; Peterson-Roth E; Liu Y; Fernandez RJ; Pike LR; Qian JM; Abriola L; Hoyer D; Hungerford W; Merkel J; Glazer PM
Mol Cancer Res; 2015 Oct; 13(10):1389-97. PubMed ID: 26116172
[TBL] [Abstract][Full Text] [Related]
14. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
15. Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma.
Coquery N; Pannetier N; Farion R; Herbette A; Azurmendi L; Clarencon D; Bauge S; Josserand V; Rome C; Coll JL; Sun JS; Barbier EL; Dutreix M; Remy CC
PLoS One; 2012; 7(7):e40567. PubMed ID: 22815765
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
17. Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer.
Devun F; Bousquet G; Biau J; Herbette A; Roulin C; Berger F; Sun JS; Robine S; Dutreix M
J Gastroenterol; 2012 Mar; 47(3):266-75. PubMed ID: 22068457
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA damage repair by artificial activation of PARP with siDNA.
Croset A; Cordelières FP; Berthault N; Buhler C; Sun JS; Quanz M; Dutreix M
Nucleic Acids Res; 2013 Aug; 41(15):7344-55. PubMed ID: 23761435
[TBL] [Abstract][Full Text] [Related]
19. The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline.
Theron T; Binder A; Verheye-Dua F; Böhm L
Int J Radiat Biol; 2000 Sep; 76(9):1197-208. PubMed ID: 10993631
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.
Yao H; Qiu H; Shao Z; Wang G; Wang J; Yao Y; Xin Y; Zhou M; Wang AZ; Zhang L
Nanomedicine; 2016 Nov; 12(8):2261-2271. PubMed ID: 27389144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
